product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PKR (N216) Antibody
catalog :
2766
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig st1
Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
Nakamura K, Aizawa K, Aung K, Yamauchi J, Tanoue A. Zebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells. Sci Rep. 2017;7:41093 pubmed publisher
Nakamura K, Aizawa K, Nakabayashi K, Kato N, Yamauchi J, Hata K, et al. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis. PLoS ONE. 2013;8:e54036 pubmed publisher
product information
SKU :
2766S
Product-Name :
PKR (N216) Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Protein Folding and Trafficking
Shipping-Temp :
COLD
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
74
Host :
Rabbit
Target :
PKR
Primary-Protein :
PKR
Alt-Names :
E2AK2,EIF2AK1,EIF2AK2,Eukaryotic translation initiation factor 2-alpha kinase 2,Interferon-induced, double-stranded RNA-activated protein kinase,Interferon-inducible RNA-dependent protein kinase,MGC126524,P1/eIF-2A protein kinase,PKR,PRKR,Protein kinase RNA-activated,double stranded RNA activated protein kinase,eIF-2A protein kinase 2,interferon-inducible elF2alpha kinase,p68 kinase,protein kinase, interferon-inducible double stranded RNA dependent
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.